awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47132309-770A0891-8E87-4023-8989-B55BB77889CA
Q47132309-770A0891-8E87-4023-8989-B55BB77889CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47132309-770A0891-8E87-4023-8989-B55BB77889CA
Aflibercept in macular edema secondary to retinal vein occlusion: A real life study.
P2860
Q47132309-770A0891-8E87-4023-8989-B55BB77889CA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47132309-770A0891-8E87-4023-8989-B55BB77889CA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93b5f8016815739fa27cc691ca3d0349dc17e170
P2860
Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data.